Detalhe da pesquisa
1.
Comparative effectiveness of tofacitinib and tumour necrosis factor inhibitors in patients with rheumatoid arthritis in real-world practice: a prospective observational study.
Rheumatology (Oxford)
; 2024 Feb 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-38366621
2.
Safety and effectiveness of tofacitinib in Korean adult patients with rheumatoid arthritis: A post-marketing surveillance study.
Mod Rheumatol
; 33(6): 1087-1096, 2023 Nov 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36401881
3.
The risk factors and incidence of major infectious diseases in patients with ankylosing spondylitis receiving tumor necrosis factor inhibitors.
Mod Rheumatol
; 31(6): 1192-1201, 2021 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-33494621
4.
A multicenter, randomized, open-label pilot trial assessing the efficacy and safety of etanercept 50 mg twice weekly followed by etanercept 25 mg twice weekly, the combination of etanercept 25 mg twice weekly and acitretin, and acitretin alone in patients with moderate to severe psoriasis.
BMC Dermatol
; 16(1): 11, 2016 07 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-27455955
5.
Comparisons of treatment satisfaction and health-related quality of life in patients with rheumatoid arthritis treated with tofacitinib and adalimumab.
Arthritis Res Ther
; 25(1): 68, 2023 04 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-37106411
6.
Increased risk of herpes zoster with tofacitinib treatment in Korean patients with rheumatoid arthritis: a single-center prospective study.
Sci Rep
; 13(1): 7877, 2023 05 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-37188765
7.
Real-world treatment patterns for atopic dermatitis in South Korea.
Sci Rep
; 12(1): 13626, 2022 08 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-35948589
8.
Treatment pattern, satisfaction, and productivity loss of patients with ankylosing spondylitis treated with tumor necrosis factor inhibitors in Korea: A multicenter cross-sectional observational study.
Int J Rheum Dis
; 25(5): 523-531, 2022 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-35187866
9.
Real-World Incidence of Suboptimal Response to Anti-Tumor Necrosis Factor Therapy for Ulcerative Colitis: A Nationwide Population-Based Study.
Gut Liver
; 15(6): 867-877, 2021 11 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-33785664
10.
Comparative Cost-Effectiveness of Tofacitinib With Continuing Conventional Synthetic Disease-Modifying Anti-Rheumatic Drugs for Active Rheumatoid Arthritis in South Korea.
Rheumatol Ther
; 8(1): 395-409, 2021 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-33496958
11.
Dose Reduction of Tumor Necrosis Factor Inhibitor and its Effect on Medical Costs for Patients with Ankylosing Spondylitis.
Rheumatol Ther
; 8(1): 347-359, 2021 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-33420967
12.
Difference of body compositional changes according to the presence of weight cycling in a community-based weight control program.
J Korean Med Sci
; 25(1): 49-53, 2010 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-20052347
13.
Cep215 is essential for morphological differentiation of astrocytes.
Sci Rep
; 10(1): 17000, 2020 10 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-33046744
14.
HDAC3 and HDAC8 are required for cilia assembly and elongation.
Biol Open
; 8(8)2019 Aug 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-31362948
15.
Efficacy and safety of tofacitinib for the treatment of rheumatoid arthritis in patients from the Asia-Pacific region: Post-hoc analyses of pooled clinical study data.
Int J Rheum Dis
; 22(6): 1094-1106, 2019 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-30900375
16.
Hospital Utilization and Medication Prescriptions among Patients with Atopic Dermatitis in South Korea: A Real-World Data Analysis.
Ann Dermatol
; 35(5): 374-388, 2023 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-37830420